The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Atossa Therapeutics Inc (NASDAQ: ATOS) was $1.41 for the day, down -4.08% from the previous closing price of $1.47. In other words, the price has decreased by -$4.08 from its previous closing price. On the day, 0.51 million shares were traded. ATOS stock price reached its highest trading level at $1.48 during the session, while it also had its lowest trading level at $1.4.
Ratios:
Our analysis of ATOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.35 and its Current Ratio is at 14.35. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 10 ’24 when Finn Jonathan bought 25,000 shares for $1.77 per share. The transaction valued at 44,250 led to the insider holds 25,000 shares of the business.
WEAVER GREGORY L sold 50,000 shares of ATOS for $32,500 on Nov 15 ’23. The Former EVP, CFO, & Director now owns 55 shares after completing the transaction at $0.65 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 177317360 and an Enterprise Value of 97791960.
Stock Price History:
Over the past 52 weeks, ATOS has reached a high of $2.31, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is 2.92%, while the 200-Day Moving Average is calculated to be 10.46%.
Shares Statistics:
ATOS traded an average of 670.09K shares per day over the past three months and 605600 shares per day over the past ten days. A total of 125.76M shares are outstanding, with a floating share count of 125.71M. Insiders hold about 0.04% of the company’s shares, while institutions hold 20.98% stake in the company. Shares short for ATOS as of 1726185600 were 13180481 with a Short Ratio of 19.67, compared to 1723680000 on 12863423. Therefore, it implies a Short% of Shares Outstanding of 13180481 and a Short% of Float of 10.479999.
Earnings Estimates
Atossa Therapeutics Inc (ATOS) is currently under the scrutiny of 3.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.21 and -$0.22 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.27, with 3.0 analysts recommending between -$0.25 and -$0.29.
